FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313364553> ?p ?o ?g. }

• W4313364553 endingPage "1365" @default.
• W4313364553 startingPage "1365" @default.
• W4313364553 abstract "Rheumatoid arthritis (RA) is an autoinflammatory disease, its core treatment principle is to achieve remission as soon as possible. There is no good prediction model that can accurately predict the remission rate of patients to choose a good treatment scheme. Here, we aimed to verify the prognostic value of some inflammatory indicators in RA and establish a prediction model to predict the remission rate after treatment.A total of 223 patients were enrolled at Qilu Hospital from June 2014 to June 2020. Baseline clinical data were collected and plasma was obtained to detect the inflammatory indicators. All patients were treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). All patients were followed up and were recorded the time to reach the disease activity score-28 with erythrocyte sedimentation rate (DAS28-ESR) of <2.6. A total of 156 patients were randomly assigned to the development cohort, and 67 patients were assigned to the validation cohort. Inflammatory indicators in plasma were detected by enzyme-linked immunosorbent assay (ELISA). The predictive factors were screeded by using least absolute shrinkage and selection operator (LASSO) and Cox regression. The model was created and verified by using the standard method. A total of 6 independent risk factors were analyzed to construct a nomogram to predict the remission rate in 3, 6 and 12 months.The remission rates after treatment in 3, 6 and 12 months were 38.76%, 58.91%, and 81.40%, respectively. Patient age, C-reactive protein (CRP), interleukin (IL)-6, galectin-9 (Gal-9), health assessment questionnaire (HAQ), and DAS28-ESR were included in the prognostic model to predict the remission rate. The resulting model had good discrimination ability in both the development cohort (C-index, 0.729) and the validation cohort (C-index, 0.710). Time-dependent receiver operating characteristic (ROC) curve, calibration analysis, and decision curve analysis (DCA) showed that the model has significant discriminant power and clinical practicability in predicting the remission rate.We established a new predictive model and validated it. The model can predict the remission rate in 3, 6 and 12 months after receiving csDMARDs treatment. By using this model, we can facilitate the identification of high-risk patients early and intervene with them as soon as possible." @default.
• W4313364553 created "2023-01-06" @default.
• W4313364553 creator A5010479652 @default.
• W4313364553 creator A5014012352 @default.
• W4313364553 creator A5025488444 @default.
• W4313364553 creator A5030071648 @default.
• W4313364553 creator A5049239359 @default.
• W4313364553 creator A5051142757 @default.
• W4313364553 creator A5058305195 @default.
• W4313364553 creator A5073777794 @default.
• W4313364553 date "2022-12-01" @default.
• W4313364553 modified "2023-09-30" @default.
• W4313364553 title "Establishment and verification of a nomogram and a preliminary study on predicting the clinical response of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis patients" @default.
• W4313364553 cites W1588610010 @default.
• W4313364553 cites W1593070855 @default.
• W4313364553 cites W1761300068 @default.
• W4313364553 cites W1920014602 @default.
• W4313364553 cites W2016300251 @default.
• W4313364553 cites W2023976647 @default.
• W4313364553 cites W2047008967 @default.
• W4313364553 cites W2093368037 @default.
• W4313364553 cites W2094765065 @default.
• W4313364553 cites W2106848258 @default.
• W4313364553 cites W2116558079 @default.
• W4313364553 cites W2120393706 @default.
• W4313364553 cites W2131120529 @default.
• W4313364553 cites W2135655382 @default.
• W4313364553 cites W2146976291 @default.
• W4313364553 cites W2166035803 @default.
• W4313364553 cites W2167862457 @default.
• W4313364553 cites W2169532722 @default.
• W4313364553 cites W2206432491 @default.
• W4313364553 cites W2589082990 @default.
• W4313364553 cites W2753090874 @default.
• W4313364553 cites W2895590824 @default.
• W4313364553 cites W2906432502 @default.
• W4313364553 cites W2908438882 @default.
• W4313364553 cites W2946652870 @default.
• W4313364553 cites W2967326556 @default.
• W4313364553 cites W2997155925 @default.
• W4313364553 cites W3022414345 @default.
• W4313364553 cites W3092189697 @default.
• W4313364553 cites W3093799301 @default.
• W4313364553 cites W3112519253 @default.
• W4313364553 cites W3119262925 @default.
• W4313364553 cites W3135377562 @default.
• W4313364553 cites W3136074794 @default.
• W4313364553 cites W3160596120 @default.
• W4313364553 cites W3161762210 @default.
• W4313364553 cites W3209469877 @default.
• W4313364553 cites W3210124512 @default.
• W4313364553 cites W4288425153 @default.
• W4313364553 doi "https://doi.org/10.21037/atm-22-5791" @default.
• W4313364553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36660697" @default.
• W4313364553 hasPublicationYear "2022" @default.
• W4313364553 type Work @default.
• W4313364553 citedByCount "0" @default.
• W4313364553 crossrefType "journal-article" @default.
• W4313364553 hasAuthorship W4313364553A5010479652 @default.
• W4313364553 hasAuthorship W4313364553A5014012352 @default.
• W4313364553 hasAuthorship W4313364553A5025488444 @default.
• W4313364553 hasAuthorship W4313364553A5030071648 @default.
• W4313364553 hasAuthorship W4313364553A5049239359 @default.
• W4313364553 hasAuthorship W4313364553A5051142757 @default.
• W4313364553 hasAuthorship W4313364553A5058305195 @default.
• W4313364553 hasAuthorship W4313364553A5073777794 @default.
• W4313364553 hasBestOaLocation W43133645531 @default.
• W4313364553 hasConcept C126322002 @default.
• W4313364553 hasConcept C1862650 @default.
• W4313364553 hasConcept C2777575956 @default.
• W4313364553 hasConcept C2778143017 @default.
• W4313364553 hasConcept C2779134260 @default.
• W4313364553 hasConcept C2781059491 @default.
• W4313364553 hasConcept C34626388 @default.
• W4313364553 hasConcept C50382708 @default.
• W4313364553 hasConcept C71924100 @default.
• W4313364553 hasConcept C72563966 @default.
• W4313364553 hasConceptScore W4313364553C126322002 @default.
• W4313364553 hasConceptScore W4313364553C1862650 @default.
• W4313364553 hasConceptScore W4313364553C2777575956 @default.
• W4313364553 hasConceptScore W4313364553C2778143017 @default.
• W4313364553 hasConceptScore W4313364553C2779134260 @default.
• W4313364553 hasConceptScore W4313364553C2781059491 @default.
• W4313364553 hasConceptScore W4313364553C34626388 @default.
• W4313364553 hasConceptScore W4313364553C50382708 @default.
• W4313364553 hasConceptScore W4313364553C71924100 @default.
• W4313364553 hasConceptScore W4313364553C72563966 @default.
• W4313364553 hasIssue "24" @default.
• W4313364553 hasLocation W43133645531 @default.
• W4313364553 hasLocation W43133645532 @default.
• W4313364553 hasLocation W43133645533 @default.
• W4313364553 hasOpenAccess W4313364553 @default.
• W4313364553 hasPrimaryLocation W43133645531 @default.
• W4313364553 hasRelatedWork W12595381 @default.
• W4313364553 hasRelatedWork W2059515661 @default.
• W4313364553 hasRelatedWork W2065131845 @default.
• W4313364553 hasRelatedWork W2317243404 @default.
• W4313364553 hasRelatedWork W231923922 @default.

• next